DiaMedica Therapeutics Inc. — Investor Relations & Filings
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for serious ischemic and vascular diseases with significant unmet medical needs. The company's lead drug candidate is DM199, a recombinant form of the human tissue kallikrein-1 (rhKLK1) protein. DM199 is designed to restore vascular health and function through a novel mechanism of action, aiming to improve patient outcomes by reversing the effects of ischemic injury. The development programs are primarily focused on treating acute ischemic stroke (AIS), preeclampsia (PE), and fetal growth restriction (FGR), conditions for which there are currently limited or no approved therapies available to address the underlying disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-06 | English | |
| 4 Filing | 2026-01-06 | English | |
| 4 Filing | 2026-01-06 | English | |
| 4 Filing | 2026-01-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 29411421 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29411396 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29411398 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 29411401 | 4 Filing | 2026-01-06 | English | ||
| 29411400 | 4 Filing | 2026-01-06 | English | ||
| 29411386 | 4 Filing | 2026-01-06 | English | ||
| 12157498 | FORM 8-K | 2026-01-05 | English | ||
|
2025
8 filings
| |||||
| 12157495 | FORM 8-K | 2025-12-18 | English | ||
| 12157499 | OWNERSHIP DOCUMENT | 2025-12-08 | English | ||
| 12157500 | Director's Dealing 2025 | 2025-11-25 | English | ||
| 12157504 | FORM S-8 | 2025-11-13 | English | ||
| 12157508 | FORM 10-Q | 2025-11-12 | English | ||
| 12157502 | FORM 8-K | 2025-11-12 | English | ||
| 12157509 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 12157510 | Director's Dealing 2025 | 2025-11-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
DiaMedica Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33140/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33140 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33140 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33140 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33140}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DiaMedica Therapeutics Inc. (id: 33140)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.